A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

HIGHLIGHTS

• who: Andrew F. Berdel from the Department of Medicine A, University Hospital Mu00fcnster, Albertu2011Schweitzeru2011Campus, Mu00fcnster, Germany have published the research work: A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy, in the Journal: (JOURNAL) of July/27,/2021
• what: The authors report the findings of the randomized, double-blind, placebocontrolled phase 2 part of the study. The study was approved by the joined Ethics Committee of the Physicians Chamber of Westphalia-Lippe and the University of Muenster, Germany, and conducted in accordance . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.